awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33419897-3E5B07C1-1CA5-43E3-885E-817B052CAD96
Q33419897-3E5B07C1-1CA5-43E3-885E-817B052CAD96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33419897-3E5B07C1-1CA5-43E3-885E-817B052CAD96
Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
P433
Q33419897-3E5B07C1-1CA5-43E3-885E-817B052CAD96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33419897-3E5B07C1-1CA5-43E3-885E-817B052CAD96
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
350478290c52a9e516a991e0a31429447dcc6d5a
P433
9
http://www.w3.org/2001/XMLSchema#string